tiprankstipranks
Poniard Pharmaceuticals (PARD)
OTHER OTC:PARD
US Market

Poniard Pharmaceuticals (PARD) Similar Stocks

7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Poniard Pharmaceuticals
0.00%
premium
MannKind
$1.25B
194.49
-4.17%
4 Buy
1 Hold
0 Sell
Strong Buy
premium
ImmunoCellular Therapeutics
$22.54M
-8.50
-42.86%
premium
Curis
$69.55M
-1.36
-33.67%
3 Buy
0 Hold
0 Sell
Strong Buy
premium
Nanobac Pharmaceuticals
premium

Performance Comparison

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis